Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.
Also called NCT03329599
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 148 participants
- Registry
-
NCT03329599
-
- Other papers using this trial's data
- A cardiovascular polypill for secondary stroke prevention in a tertiary centre in Ghana (SMAART): a phase 2 randomised clinical trial
- Effect of a Cardiovascular Polypill on Poststroke Cognition Among Ghanaians: Secondary Analysis of a Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Ghana
- Registry status
- Completed
Technical summary
Registry record NCT03329599. Randomized; quadruple masking; primary purpose treatment. Start 2019-02-14 (actual); primary completion 2021-12-01 (actual). Results posted on 2023-12-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment
- Condition
- Atherosclerosis
- Condition
- Adherence, Medication
- Condition
- Tolerance
- Intervention (Drug)
- Polycap
- Lead sponsor
- Northern California Institute of Research and Education
- Collaborator
- Kwame Nkrumah University Teaching Hospital
Record details
- Record id
cardio:ct-nct03329599- Content hash
b14da09d6155f578719a6c062c3c1b92a3fad0257b4425a18533eddf2a52772e